GBA1 and Parkinson disease: Moreover, glucocerebrosidase (GBA) gene mutations exacerbate cognitive decline in PD by disrupting lysosomal function and α-synuclein metabolism, leading to toxic protein aggregation and impaired synaptic plasticity (Chang et al., 2024).